Artemilife

University of Kentucky Markey Cancer Center researchers presented promising results fr om an early-stage clinical trial investigating a unique coffee-based approach to ovarian cancer maintenance therapy at the Society of Gynecologic Oncology annual meeting in Seattle.

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial investigating a unique coffee-based approach to ovarian cancer maintenance therapy at the Society of Gynecologic Oncology annual meeting in Seattle (SGO 2025).

Read article at: https://ascopubs.org/doi/10.1200/JCO.2024.42.4_suppl.TPS350

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial investigating a unique coffee-based approach to ovarian cancer maintenance therapy at the Society of Gynecologic Oncology annual meeting in Seattle.

ArtemiLife was founded with a simple mission: to create products to help you take control of your health and well-being for life.

This Privacy Policy ("Service") is owned and operated by ArtemiLife™Incorporated, LCC ("ArtemiLife™ Incorporated", "we", "our", or "us".

Please read these Terms carefully before using our websites and any online services, software or apps provided by ArtemiLife™ Incorporated (“ArtemiLife™ Incorporated”, “we”, or “us” or “our”) that post a link to these Terms (the “Service”). The Service is operated by ArtemiLife™ Incorporated. ArtemiLife™ Incorporated offers this Service, including all information, tools and services available from this Service to you, the user, conditioned upon your acceptance of all terms, conditions, policies

ArtemiLife was founded with a simple mission: to create products to help you take control of your health and well-being for life.